| 000 | 00769na a2200205 4500 | ||
|---|---|---|---|
| 003 | H12O | ||
| 005 | 20180417105948.0 | ||
| 008 | 130622s2011 xxx||||| |||| 00| 0 eng d | ||
| 040 | _cH12O | ||
| 041 | _aeng | ||
| 100 |
_9539 _aRuilope Urioste, Luis Miguel _eNefrología |
||
| 245 | 0 | 0 |
_aSafety aspects of aldosterone-blocking drugs _h[artículo] |
| 260 |
_bEuropean Heart Journal Supplements, _c2011 |
||
| 300 | _a13(Sup B):B40-B42. | ||
| 500 | _aFormato Vancouver: Ruilope LM. Safety aspects of aldosterone-blocking drugs. Eur Heart J Suppl. 2011;16(Suppl B):B40-B42. | ||
| 504 | _aContiene 19 referencias. | ||
| 710 |
_986 _aServicio de Nefrología |
||
| 856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc14507.pdf _ySolicitar documento |
||
| 942 |
_n0 _2ddc _cART |
||
| 999 |
_c14507 _d14507 |
||